Roles of HOXC gene in tumors

doi:10.3760/cma.j.issn.1673-422X.2019.03.011

Abstract

Abstract: The protein encoded by the HOXC gene regulates multiple processes during embryonic development, including cell growth, differentiation, apoptosis, migration and angiogenesis. The HOXC gene is also involved in the occurrence and development of various human solid tumors, such as colorectal cancer, gastric cancer, liver cancer, breast cancer, endometrial cancer, etc. In addition, the HOXC gene is closely related to the clinical stage and distant metastasis of the tumor. Thus, the HOXC gene can be used as a biological predictor of tumor metastasis and prognosis.

Key words: Neoplasms, Genes, homeobox, HOXC

Li Jingzhang, Ni Bingqiang. Roles of HOXC gene in tumors[J]. Journal of International Oncology, 2019, 46(3): 181-185.

References

［1］ Bhatlekar S, Fields JZ, Boman BM. HOX genes and their role in the development of humancancers［J］. J Mol Med (Berl), 2014, 92(8): 811823. DOI: 10.1007/s001090141181y. ［2］ Vider BZ, Zimber A, Chastre E, et al. Deregulated expression of homeoboxcontaining genes, HOXB6, B8, C8, C9, and Cdx1, in human colon cancer cell lines［J］. Biochem Biophys Res Commun, 2000, 272(2): 513518. DOI: 10.1006/bbrc.2000.2804. ［3］ Luo J, Wang Z, Huang J, et al. HOXC13 promotes proliferation of esophageal squamous cell carcinoma via repressing transcription of CASP3［J］. Cancer Sci, 2018, 109(2): 317329. DOI: 10.1111/cas.13453. ［4］ Hur H, Lee JY, Yun HJ, et al. Analysis of HOX gene expression patterns in human breast cancer［J］. Mol Biotechnol, 2014, 56(1): 6471. DOI: 10.1007/s1203301396824. ［5］ Du YB, Dong B, Shen LY, et al. The survival predictive significance of HOXC6 and HOXC8 in esophageal squamous cell carcinoma［J］. J Surg Res, 2014, 188(2): 442450. DOI: 10.1016/j.jss.2014.01.017. ［6］ Zhang Q, Jin XS, Yang ZY, et al. Upregulated Hoxc6 expression is associated with poor survival in gastric cancer patients［J］. Neoplasma, 2013, 60(4): 439445. DOI: 10.4149/neo_2013_057. ［7］ Chen SW, Zhang Q, Xu ZF, et al. HOXC6 promotes gastric cancer cell invasion by upregulating the expression of MMP9［J］. Mol Med Rep, 2016, 14(4): 32613268. DOI: 10.3892/mmr.2016.5640. ［8］ Guo C, Hou J, Ao S, et al. HOXC10 upregulation promotes gastric cancer cell proliferation and metastasis through MAPK pathway［J］. Chin J Cancer Res, 2017, 29(6): 572580. DOI: 10.21147/j.issn.10009604. ［9］ Peng X, Kang Q, Wan R, et al. miR26a/HOXC9 dysregulation promotes metastasis and stem celllike phenotype of gastric cancer［J］. Cell Physiol Biochem, 2018, 49(4): 16591676. DOI: 10.1159/000493502. ［10］ Vider BZ, Zimber A, Hirsch D. Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression［J］. Biochem Biophys Res Commun, 1997, 232(3): 742748. DOI: 10.1006/bbrc.1997.6364. ［11］ Kasiri S, Ansari KI, Hussain I, et al. Antisense oligonucleotide mediated knockdown of HOXC13 affects cell growth and inducesapoptosis in tumor cells and over expression of HOXC13 induces 3Dcolony formation［J］. RSC Adv, 2013, 3(10): 32603269. DOI: 10.1039/C2RA22006G. ［12］ Ansari KI, Hussain I, Shrestha B, et al. HOXC6 is transcriptionally regulated via coordination of MLL histone methylase and estrogen receptor in an estrogen environment［J］. J Mol Biol, 2011, 411(2): 334349. DOI: 10.1016/j.jmb.2011.05.050. ［13］ Hussain I, Bhan A, Ansari KI, et al. BisphenolA induces expression of HOXC6, an estrogenregulated homeoboxcontaining gene associated with breast cancer［J］. Biochim Biophys Acta, 2015, 1849(6): 697708. DOI: 10.1016/j.bbagrm.2015.02.003. ［14］ Li Y, Zhang M, Chen H, et al. Ratio of miR196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis［J］. Cancer Res, 2010, 70(20): 78947904. DOI: 10.1158/00085472.CAN101675. ［15］ Li Y, Guo Z, Chen H, et al. HOXC8dependent cadherin 11 expression facilitates breast cancer cell migration through Trio and Rac［J］. Genes Cancer, 2011, 2(9): 880888. DOI: 10.1177/1947601911433129. ［16］ Ansari KI, Hussain I, Kasiri S, et al. HOXC10 is overexpressed in breast cancer and transcriptionally regulated by estrogen via involvement of histone methylases MLL3 and MLL4［J］. J Mol Endocrinol, 2012, 48(1): 6175. DOI: 10.1530/JME110078. ［17］ Pathiraja TN, Nayak SR, Xi Y, et al. Epigenetic reprogramming of HOXC10 in endocrineresistant breast cancer［J］. Sci Transl Med, 2014, 6(229): 229ra41. DOI: 10.1126/scitranslmed.3008326. ［18］ Sadik H, Korangath P, Nguyen N, et al. HOXC10 expression supports the development of chemotherapy resistance by fine tuning DNA repair in breast cancer cells［J］. Cancer Res, 2016, 76(15): 44434456. DOI: 10.1158/00085472.CAN160774. ［19］ Saha SS, Chowdhury RR, Mondal NR, et al. Expression signatures of HOX cluster genes in cervical cancer pathogenesis: impact of human papillomavirus type 16 oncoprotein E7［J］. Oncotarget, 2017, 8(22): 3659136602. DOI: 10.18632/oncotarget.16619. ［20］ Huang Y, Chen L, Guo A. Upregulated expression of HOXC8 is associated with poor prognosis of cervical cancer［J］. Oncol Lett, 2018, 15(5): 72917296. DOI: 10.3892/ol.2018.8200. ［21］ Eoh KJ, Kim HJ, Lee JY, et al. Upregulation of homeobox gene is correlated with poor survival outcomes in cervical cancer［J］. Oncotarget, 2017, 8(48): 8439684402. DOI: 10.18632/oncotarget.21041. ［22］ Zhai Y, Kuick R, Nan B, et al. Gene expression analysis of preinvasive and invasive cervical squamous cell carcinomas identifies HOXC10 as a key mediator of invasion［J］. Cancer Res, 2007, 67(21): 1016310172. DOI: 10.1158/00085472.CAN072056. ［23］ Lu S, Liu R, Su M, et al. Overexpression of HOXC8 is associated with poor prognosis in epithelial ovarian cancer［J］. Reprod Sci, 2016, 23(7): 944954. DOI: 10.1177/1933719115625845. ［24］ Eoh KJ, Kim HJ, Lee JY, et al. Dysregulated expression of homeobox family genes may influence survival outcomes of patients with epithelial ovarian cancer: analysis of data from The Cancer Genome Atlas［J］. Oncotarget, 2017, 8(41): 7057970585. DOI: 10.18632/oncotarget.19771. ［25］ Yamashita T, Tazawa S, Yawei Z, et al. Suppression of invasive characteristics by antisense introduction of overexpressed HOX genes in ovarian cancer cells［J］. Int J Oncol, 2006, 28(4): 931938. DOI: 10.3892/ijo.28.4.931. ［26］ Cantile M, Cindolo L, Napodano G, et al. Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas［J］. Oncogene, 2003, 22(41): 64626468. DOI: 10.1038/sj.onc.1206808. ［27］ Lv L, Li Y, Deng H, et al. MiR193a3p promotes the multichemoresistance of bladder cancer by targeting the HOXC9 gene［J］. Cancer Lett, 2015, 357(1): 105113. DOI: 10.1016/j.canlet.2014.11.002. ［28］ Cantile M, Schiavo G, Franco R, et al. Expression of lumbosacral HOX genes, crucial in kidney organogenesis, is systematically deregulated in clear cell kidney cancers［J］. Anticancer Drugs, 2011, 22(5): 392401. DOI: 10.1097/CAD.0b013e32834505d3. ［29］ Liu YJ, Zhu Y, Yuan HX, et al. Overexpression of HOXC11 homeobox gene in clear cell renal cell carcinoma induces cellular proliferation and is associated with poor prognosis［J］. Tumour Biol, 2015, 36(4): 28212829. DOI: 10.1007/s1327701429096. ［30］ Omatu T. Overexpression of human homeobox gene in lung cancer A549 cells results in enhanced motile and invasive properties［J］. Hokkaido Igaku Zasshi, 1999, 74(5): 367376. ［31］ Tang XL, Ding BX, Hua Y, et al. HOXC10 promotes the metastasis of human lung adenocarcinoma and indicates poor survival outcome［J］. Front Physiol, 2017, 8: 557. DOI: 10.3389/fphys.2017.00557. ［32］ Yao Y, Luo J, Sun Q, et al. HOXC13 promotes proliferation of lung adenocarcinoma via modulation of CCND1 and CCNE1［J］. Am J Cancer Res, 2017, 7(9): 18201834. ［33］ Liu H, Zhang M, Xu S, et al. HOXC8 promotes proliferation and migration through transcriptional upregulation of TGFβ1 in nonsmall cell lung cancer［J］. Oncogenesis, 2018, 7(2): 1. DOI: 10.1038/s4138901700164. ［34］ Guo YB, Shao YM, Chen J, et al. Effect of overexpression of HOX genes on its invasive tendency in cerebral glioma［J］. Oncol Lett, 2016, 11(1): 7580. DOI: 10.3892/ol.2015.3893. ［35］ Xuan F, Huang M, Liu W, et al. Homeobox C9 suppresses Beclin1mediated autophagy in glioblastoma by directly inhibiting the transcription of deathassociated protein kinase 1［J］. Neuro Oncol, 2016, 18(6): 819829. DOI: 10.1093/neuonc/nov281.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.